Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type K Maurer, R Ihl, T Dierks, L Frölich Journal of psychiatric research 31 (6), 645-655, 1997 | 321 | 1997 |
Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial G Weyer, H Erzigkeit, S Kanowski, R Ihl, D Hadler International psychogeriatrics 9 (2), 123-138, 1997 | 179 | 1997 |
Differential validity of psychometric tests in dementia of the Alzheimer type R Ihl, L Frölich, T Dierks, EM Martin, K Maurer Psychiatry research 44 (2), 93-106, 1992 | 177 | 1992 |
Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources T Dierks, R Ihl, L Frölich, K Maurer Psychiatry Research: Neuroimaging 50 (3), 151-162, 1993 | 176 | 1993 |
Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer’s disease and vascular dementia: results from a randomised controlled trial R Ihl, M Tribanek, N Bachinskaya, GOTADAY Study Group Pharmacopsychiatry 45 (02), 41-46, 2012 | 168 | 2012 |
Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial R Ihl, N Bachinskaya, AD Korczyn, V Vakhapova, M Tribanek, R Hoerr, ... International journal of geriatric psychiatry 26 (11), 1186-1194, 2011 | 165 | 2011 |
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? P Robert, S Ferris, S Gauthier, R Ihl, B Winblad, F Tennigkeit Alzheimer's research & therapy 2, 1-13, 2010 | 153 | 2010 |
Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind … S Yancheva, R Ihl, G Nikolova, P Panayotov, S Schlaefke, R Hoerr, ... Aging and Mental Health 13 (2), 183-190, 2009 | 153 | 2009 |
Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia T Dierks, I Perisic, L Frölich, R Ihl, K Maurer Psychiatry Research: Neuroimaging 40 (3), 181-194, 1991 | 148 | 1991 |
Electrophysiological correlates of emotional and structural face processing in humans M Streit, W Wölwer, J Brinkmeyer, R Ihl, W Gaebel Neuroscience Letters 278 (1-2), 13-16, 2000 | 140 | 2000 |
Entwicklung und Validierung eines Tests zur Früherkennung der Demenz mit Depressionsabgrenzung (TFDD) R Ihl, B Grass-Kapanke, P Lahrem, J Brinkmeyer, S Fischer, N Gaab, ... Fortschritte der Neurologie· Psychiatrie 68 (09), 413-422, 2000 | 137 | 2000 |
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761® N Kandiah, PA Ong, T Yuda, LL Ng, K Mamun, RA Merchant, C Chen, ... CNS neuroscience & therapeutics 25 (2), 288-298, 2019 | 133 | 2019 |
Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1‐year follow‐up study C Luckhaus, B Grass‐Kapanke, I Blaeser, R Ihl, T Supprian, G Winterer, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2008 | 121 | 2008 |
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report R Bordet, R Ihl, AD Korczyn, G Lanza, J Jansa, R Hoerr, A Guekht BMC medicine 15, 1-12, 2017 | 111 | 2017 |
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias R Ihl, L Froelich, B Winblad, L Schneider, A Burns, HJ Moeller, ... The World Journal of Biological Psychiatry 12 (1), 2-32, 2011 | 102 | 2011 |
EEG-correlates of facial affect recognition and categorisation of blurred faces in schizophrenic patients and healthy volunteers M Streit, W Wölwer, J Brinkmeyer, R Ihl, W Gaebel Schizophrenia Research 49 (1-2), 145-155, 2001 | 93 | 2001 |
Odor identification in Alzheimer’s disease and depression M Pentzek, B Grass-Kapanke, R Ihl Aging clinical and experimental research 19, 255-258, 2007 | 87 | 2007 |
Event-related potentials and psychopharmacology T Dierks, L Frölich, R Ihl, K Maurer Pharmacopsychiatry 27 (02), 72-74, 1994 | 84 | 1994 |
Die Reisberg-Skalen: GDS, BCRS, FAST; deutschsprachige Bearbeitung der Global Deterioration Scale, der Brief Cognitive Rating Scale und des Functional Assessment Staging von … R Ihl, L Frölich Beltz-Test, 1991 | 72 | 1991 |
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial N Bachinskaya, R Hoerr, R Ihl Neuropsychiatric Disease and Treatment, 209-215, 2011 | 71 | 2011 |